Literature DB >> 10566342

Methodology for the analysis and representation of the medical information about drugs in the Summary of Product Characteristics (SPC).

A Venot1, C Duclos.   

Abstract

We present a methodology for the representation of the medical knowledge in the drug SPCs. It includes four steps, the two first of which are automated. All instances of a particular SPC text are gathered into a single file. Lexical analysis of the content of this file is performed and a lexicon with the occurrence of words and groups of words is built. Semantic analysis is carried out considering the concepts underlying each word of the lexicon and the most important concepts are kept. This semantic analysis results in a list of attributes which are then included in an object-oriented model. We have used this method to structure drug indications. This application clearly illustrates the advantages of this method over purely manual analysis. This method could be generalized for all categories of medical information about drugs.

Mesh:

Substances:

Year:  1999        PMID: 10566342      PMCID: PMC2232762     

Source DB:  PubMed          Journal:  Proc AMIA Symp        ISSN: 1531-605X


  9 in total

1.  The need for a concept-based medication vocabulary as an enabling infrastructure in health informatics.

Authors:  W D Sperzel; C A Broverman; J E Kapusnik-Uner; J M Schlesinger
Journal:  Proc AMIA Symp       Date:  1998

Review 2.  Modeling concepts in medicine for medical language understanding.

Authors:  A M Rassinoux; R A Miller; R H Baud; J R Scherrer
Journal:  Methods Inf Med       Date:  1998-11       Impact factor: 2.176

3.  Modeling and implementing a database on drugs into a hospital intranet.

Authors:  M François; M Joubert; D Fieschi; M Fieschi
Journal:  Comput Biol Med       Date:  1998-09       Impact factor: 4.589

4.  Standardized structure and modular design of a pharmacokinetic database.

Authors:  F Keller; T Frankewitsch; D Zellner; S Simon; D Czock; M Giehl
Journal:  Comput Methods Programs Biomed       Date:  1998-02       Impact factor: 5.428

5.  Indicators for the automated analysis of drug prescribing quality.

Authors:  J Coste; B Séné; C Milstein; S Bouée; A Venot
Journal:  Methods Inf Med       Date:  1998-01       Impact factor: 2.176

6.  Object-oriented modeling and terminologies for drug contraindications.

Authors:  J H Liu; C Milstein; B Séné; A Venot
Journal:  Methods Inf Med       Date:  1998-01       Impact factor: 2.176

7.  The content coverage of clinical classifications. For The Computer-Based Patient Record Institute's Work Group on Codes & Structures.

Authors:  C G Chute; S P Cohn; K E Campbell; D E Oliver; J R Campbell
Journal:  J Am Med Inform Assoc       Date:  1996 May-Jun       Impact factor: 4.497

8.  Modeling drug information for a prescription-oriented knowledge base on drugs.

Authors:  C Milstein; I de Zegher; A Venot; B Séné; P Pietri; B Dahlberg
Journal:  Methods Inf Med       Date:  1995-09       Impact factor: 2.176

9.  A computer-assisted management program for antibiotics and other antiinfective agents.

Authors:  R S Evans; S L Pestotnik; D C Classen; T P Clemmer; L K Weaver; J F Orme; J F Lloyd; J P Burke
Journal:  N Engl J Med       Date:  1998-01-22       Impact factor: 91.245

  9 in total
  3 in total

1.  Structured representation of the pharmacodynamics section of the summary of product characteristics for antibiotics: application for automated extraction and visualization of their antimicrobial activity spectra.

Authors:  Catherine Duclos; Gian Luigi Cartolano; Michael Ghez; Alain Venot
Journal:  J Am Med Inform Assoc       Date:  2004-04-02       Impact factor: 4.497

2.  Variability in the quality of overdose advice in Summary of Product Characteristics (SPC) documents: gut decontamination recommendations for CNS drugs.

Authors:  Andrew J B Wall; D N Bateman; W S Waring
Journal:  Br J Clin Pharmacol       Date:  2008-11-17       Impact factor: 4.335

3.  Designing concept maps for a precise and objective description of pharmaceutical innovations.

Authors:  Maia Iordatii; Alain Venot; Catherine Duclos
Journal:  BMC Med Inform Decis Mak       Date:  2013-01-18       Impact factor: 2.796

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.